U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629557) titled 'Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus' on June 01.

Brief Summary: Clinical trial to evaluate the safety and feasibility of corneal cross-linking in both eyes on the same day in subjects with keratoconus.

Study Start Date: May 11

Study Type: INTERVENTIONAL

Condition: Keratoconus

Intervention: DRUG: Riboflavin Ophthalmic Solutions

Riboflavin Ophthalmic Solutions

DEVICE: UV-A Irradiation System

O2n UV-A Irradiation System

Recruitment Status: RECRUITING

Sponsor: Glaukos Corporation

Published by HT Digital Content Services with permission from Health Daily...